Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patientsarticle Published on 2023-06-102024-09-05 Journal: Journal of Cancer Research and Clinical Oncology [Category] update2024, [키워드] BA.1 BA.4/5 BQ.1.1 Cancer Neutralizing antibodies omicron SARS-CoV-2 vaccination [DOI] 10.1007/s00432-023-04961-2 PMC 바로가기 [Article Type] article
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022COVID-19 백신 접종 및 BA.1 돌발 감염은 BA.4 및 BA.5 오미크론 변이체에 대해 덜 효율적인 중화 항체를 유도, 이스라엘, 2022년 3월~6월Article Published on 2022-07-012022-09-11 Journal: Eurosurveillance [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] BA.4/5 BNT162b2 BNT162b2 vaccination Breakthrough infection COVID-19 COVID-19 vaccination dose Efficiency evaluated healthcare worker Healthcare workers IMPROVE indicated individual induce Infection less neutralising Neutralising Antibodies neutralising antibody neutralising antibody titre neutralising antibody titres Neutralizing omicron SARS-CoV-2 Vaccine vaccine dose variant variants wild type WT virus [DOI] 10.2807/1560-7917.ES.2022.27.30.2200559 PMC 바로가기 [Article Type] Article